MENU

Fox Chase Cancer Center News

April 4, 2011

MicroRNA Variations Found to be Associated with Earlier Time to Prostate Cancer Diagnosis in African American Men Undergoing Screening

ORLANDO, FL (April 4, 2011) – Prostate cancer is the second leading cause of cancer-related death among American men. Yet population-wide screening programs have not reduced the number of deaths from the disease. By focusing screening programs on the men who are at greatest risk for aggressive disease or diagnosis at a young age, researchers think they could improve mortality rates and personalize the screening approach. For that reason, scientists have been looking for genetic markers to help them identify exactly which men are at high risk and require regular screening.

April 4, 2011

Fox Chase Researchers Link Common Variant of p53 Tumor Suppressor Gene to Increased Inflammatory Responses

ORLANDO, FL (April 4, 2011) – New findings by Fox Chase Cancer Center researchers link a common variant of the powerful anticancer gene p53 to increased inflammatory responses following DNA damage. The results may help explain why African Americans, who more frequently possess this variant, tend to be more susceptible to certain kinds of inflammation-related diseases and cancers, such as type II diabetes and colorectal cancer.

Susan Conley
March 14, 2011

Author Susan Conley Shares Her Experience of Living with Cancer in China to Inaugurate Fox Chase's 2011 Author Series

PHILADELPHIA (March 14, 2011) – Fox Chase Cancer Center will open its 2011 Author Series with a reading of The Foremost Good Fortune by breast cancer survivor Susan Conley on March 30, 2011, at 7:00 p.m. in the Center’s auditorium (Center Building, 333 Cottman Avenue, Philadelphia). The event is FREE and open to the public with pre-registration. 

Beatrice Mintz, PhD
March 8, 2011

Fox Chase Cancer Center's Beatrice Mintz, PhD, Receives the 6th Annual Szent-Györgyi Prize for Progress in Cancer Research

PHILADELPHIA (March 8, 2011) – The National Foundation for Cancer Research (NFCR) announced today that Fox Chase Cancer Center’s Beatrice Mintz, PhD, has been awarded the 6th Annual Szent-Györgyi Prize for Progress in Cancer Research.  Dr.

March 1, 2011

Fox Chase Listed Among the Top Places in the Nation for Postdocs

PHILADELPHIA (March 1, 2011) – Fox Chase Cancer Center has been listed among the top 15 best places in the nation for postdoctoral researchers—also known simply as “postdocs”—to work by The Scientist’s annual Best Places to Work for Postdocs survey. Fox Chase was the only top-ranked institution in Pennsylvania and ranked 8th overall in the U.S.

February 18, 2011

Paula D. Ryan, MD, PhD, Joins Fox Chase's Department of Medical Oncology

PHILADELPHIA (February 18, 2011) – Paula D. Ryan, MD, PhD, has joined Fox Chase Cancer Center as an attending physician for the department of medical oncology. She specializes in treating patients with all stages of breast cancer, with a focus on breast cancers that are locally advanced and metastatic. Ryan has particular interest in coordinating the management of patients requiring complex care. In addition, she is committed to clinical research with a special interest in developing novel strategies and agents for the treatment of metastatic breast cancer.

January 31, 2011

Fox Chase Cancer Center Publishes Clinical Outcomes for Patient Use

PHILADELPHIA (January 31, 2011) – Fox Chase Cancer Center, one of the nation’s leading cancer research and treatment institutions, today announced the posting of clinical outcomes data to its website as a tool to assist newly-diagnosed patients in deciding where to seek cancer care. This initiative follows on a survey Fox Chase commissioned in the fall of 2010, in which non-diagnosed adults ranked success rates as the factor that would be the mostimportant in choosing a hospital if they were told that they or a family member required  cancer treatment.

January 4, 2011

Fox Chase Researchers Find Estrogen May Help Precancerous Cells Spread in Oral Cavity

PHILADELPHIA (January 4, 2011) – Head and neck cancer is the sixth most common type of cancer and is on the rise in some demographic groups, including young women without any known risk factors. Now, researchers at Fox Chase Cancer Center report that estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease within the oral cavity. The new results, which are reported in the January issue of Cancer Prevention Research, may lead to novel chemoprevention strategies in the future.

Pages

Connect with Fox Chase